Clinical Trial Update: Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies [Phase 1]

View source ↗

Summary

Phase I study evaluating the combination of valproic acid and epirubicin in patients with advanced solid tumors; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• Epirubicin (epirubicin)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Neoplasms, Advanced | Phase 1 | Status: COMPLETED